Doctor profile · Federal record

Dr. Andrew Simkin, M.D.

Dermatology Physician (CMS: Dermatology) · Chelmsford, MA

  • NPI 1730179623
  • Accepts Medicare
  • MIPS 88.9 / 100 · 2023
  • 51 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3 Village Sq
Chelmsford, MA 018242712
(978) 256-4151
fax (978) 256-3987
Mailing address
133 Salem St
Andover, MA 018102210

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
August 31, 2012
Year of graduation
1975 — 51 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Massachusetts #39025
Medicaid
MA #0120413

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730179623. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
7,178
Distinct HCPCS
10
Medicare allowed
$404,222
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 2,997 521 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 1,432 1,170 $101
17000 Destruction of precancer skin growth, 1 growth 887 661 $74
99212 Established patient office or other outpatient visit, 10-19 minutes 886 690 $64
11102 Biopsy of related skin growth, first growth 334 302 $117
17110 Destruction of skin growth, 1-14 growths 279 244 $133
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 61 11 $1
11103 Biopsy of related skin growth, each additional growth 57 50 $59
17004 Destruction of precancer skin growth, 15 or more growths 52 45 $197
11104 Punch biopsy, first skin growth 32 28 $149

In context: peer comparison

Among 1 peers in Chelmsford Dermatology Physician, average services per provider: 448. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,147
Transactions
138
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 28 $630.52
Lilly USA, LLC 21 $536.19
Janssen Biotech, INC. 17 $499.20
Dermavant Sciences, INC. 12 $275.68
Novartis Pharmaceuticals Corporation 12 $204.71
Galderma Laboratories, L.P. 12 $200.22
Genzyme Corporation 8 $193.50
E.R. Squibb & Sons, L.L.C. 12 $176.81
Pfizer INC. 4 $86.95
Ortho Dermatologics, A Division of Bausch Health US, LLC 4 $81.39
Regeneron Healthcare Solutions, INC. 3 $71.81
Ucb, INC. 1 $34.45
Leo Pharma INC. 2 $31.61
Sun Pharmaceutical Industries INC. 1 $31.11
Organon LLC 1 $26.58

By nature of payment

Food and Beverage
$3,051
Education
$96

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,225
Patients
686
Total drug cost
$41,642
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 334 172 $6,267
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 216 110 $6,463
Hydrocortisone Generic 99 51 $1,375
Ketoconazole Generic 79 35 $2,214
Fluocinonide Generic 62 42 $3,103
Doxycycline Hyclate Generic 53 42 $1,345
Halobetasol Propionate Generic 51 31 $2,220
Clobetasol Emollient (Clobetasol Propionate/Emoll) Brand 50 25 $5,816
Ciclopirox (Ciclopirox Olamine) Brand 48 30 $1,262
Fluorouracil Generic 44 42 $3,308

Frequently asked questions

Auto-generated from federal data
What is Dr. Andrew Simkin's medical specialty?
Dr. Andrew Simkin practices Dermatology Physician in Chelmsford, MA.
Where does Dr. Andrew Simkin practice?
Dr. Andrew Simkin practices at 3 Village Sq, Chelmsford, MA 018242712. Office phone: 9782564151.
What is Dr. Andrew Simkin's NPI?
Dr. Andrew Simkin's National Provider Identifier (NPI) is 1730179623, issued by NPPES.
Does Dr. Andrew Simkin accept Medicare assignment?
Yes. Dr. Andrew Simkin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Simkin commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.